Dysoxylum binectariferum Hook.f (Meliaceae), a rich source of rohitukine

Fitoterapia

Volumn 81, Issue 2, 2010, Pages 145-148

  Mohanakumara, Patel ^a   Sreejayan, Nambiar ^a   Priti, Vaidayanathan ^a,b   Ramesha, Bheemanahally Thimmappa ^a   Ravikanth, Gudasalamani ^a,b   Ganeshaiah, Kotiganahalli Narayanagowda ^a,b   Vasudeva, Ramesh ^c   Mohan, John ^e   Santhoshkumar, Thankayyan Retnabai ^e   Mishra, Prabhu Dutt ^d   Ram, Viswakarma ^d,f   Shaanker, Ramanan Uma ^a,b  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (India)

^b ASHOKA TRUST FOR RESEARCH IN ECOLOGY AND THE ENVIRONMENT   (India)

^c College of Forestry   (India)

^d Piramal Enterprises Limited   (India)

^e RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^f CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Anticancer activity; Dysoxylum binectariferum; Flavopiridol; Rohitukine

Indexed keywords

CHROMAN DERIVATIVE; DYSOXYLUM BINECTARIFERUM EXTRACT; PLANT EXTRACT; ROHITUKINE; UNCLASSIFIED DRUG;

APHANAMIXIS POLYSTACHYA; ARTICLE; BARK; BREAST CANCER; CONTROLLED STUDY; DRUG EFFECT; DYSOXYLUM BINECTARIFERUM; HUMAN; HUMAN CELL; INDIA; MELIACEAE; OVARY CANCER; PLANT STEM; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLAVONOIDS; HUMANS; INDIA; LIMONINS; MELIACEAE; NEOPLASMS; OVARIAN NEOPLASMS; PHYTOTHERAPY; PIPERIDINES; PLANT BARK; PLANT EXTRACTS; PLANT STEMS; PROTEIN KINASE INHIBITORS; TREES;

AMOORA ROHITUKA; DYSOXYLUM; MELIACEAE;

EID: 72549111088     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2009.08.010     Document Type: Article

References (23)

1. Harmon A.D., Weiss U., and Silverton J.V. Tetrahedron Lett 8 (1979) 721
2. Naik R., Ramachandra G., Kattige S.L., Bhat S.V., Alreja B., De Souza N.J., and Rupp R.H. Tetrahedron 44 (1988) 2081
3. Carlson B.A., Dubay M.M., Sausville E.A., Brizuela L., and Worland P.J.F. Cancer Res 56 (1996) 2973
4. Sedlacek H.H., Czech J., Naik R., Kaur G., Worland P., Losiewicz M., et al. Int J Oncol 9 (1996) 1143
5. Sausville E.A., Zaharevitz D., Gussio R., Meijer L., Louarn-Leost M., Kunick C., et al. Pharmacol Ther 82 (1999) 285
6. Takada Y., and Aggarwal B.B. J Bio Chem 278 (2003) 23390
7. Senderowicz A.M., Headlee D., Stinson S.F., Lush R.M., Kalil N., Villalba L., et al. J Clin Oncol 16 (1998) 2986
8. Senderowicz A.M., and Sausville E.A. J Natl Cancer Inst 92 (2000) 376
9. Stadler W.M., Vogelzang N.J., Amato R., Sosman J., Taber D., Liebowitz D., et al. J Clin Oncol 18 (2000) 371
10. Byrd J.C., Lin T.S., Dalton J.T., Phelps M., Fischer B., Moran M., et al. J Clin Oncol 24 (2006) 6516
11. Karp J.E., Douglas S.B., Levis M.J., Gore S.D., Greer J., Hattenburg C., et al. Clin Cancer Res 13 (2007) 4467
12. Cragg G.M., and Newman D.J. Pure Appl Chem 77 (2005) 1923
13. Dancey J., and Sausville E.A. Nat Rev Drug Discovery 2 (2003) 296
14. Biglione S., Byers S.A., Price J.P., Nguyen V.T., Bensaude O., Price D.H., and Maury W. Retrovirology 4 (2007) 47
15. Perkins K.J., Lusic M., Mitar I., Giacca M., and Proudfoot N.J. Mol. cell 29 (2008) 56
16. Govind K., Oberoi R.M., Lakshmi V., Pandey K., and Singh M.M. Contraception 76 (2007) 400
17. Fischer P.M., and Lane D.P. Curr Med Chem 7 (2000) 1213
18. Kelland L.R. Expert Opin Inv Drugs 9 (2000) 2903
19. da Rocha A., Lopes R., and Schwartsmann G. Curr Opin Pharmacol 1 (2001) 364
20. Myers N., Mittermeier R.A., Mittermeier C.G., daFonseca G.A.B., and Kent J. Nature 403 (2000) 853
21. Yang D.H., Cai S.Q., Zhao Y.Y., and Liang H.A. J Asian Nat Prod Res 6 (2004) 233
22. Yang D.H., Cai S.Q., Zhao Y.Y., and Linang H. Chin Chem Lett 14 (2003) 720
23. Watts C., Brady A., Sarcevic B., deFazio A., Musgrove E., and Sutherland R. Mol Endocrinol 9 (2009) 1804